Table 3.

Prevalence of other autoimmune diseases associated with diabetes mellitus in patients without, with less and more than 297 days partial clinical remission.

	Without partial clinical remission	Partial clinical Remission <297 days	Partial clinical Remission ≥ 297 days
Diabetes mellitus	26 (74%)	11 (61%)	68 (64%)
Diabetes mellitus + 1 other autoimmune disease	8 (23%)	5 (28%)	35 (33%)
Diabetes mellitus + 2 other autoimmune diseases	1 (3%)	2 (11%)	3 (3%)

Eight (23%) of the patients who did not experience a phase of Partial Clinical Remission had been followed-up with DM and 1 other autoimmune disease. Five (28%) of the patients who experienced less than 297 days, a phase of Partial Clinical Remission had been followed-up with DM and 1 other autoimmune disease. Thirty-five (33%) of the patients who experienced more than 297 days a phase of Partial Clinical Remission had been followed-up with DM and 1 other autoimmune disease. This results show that clinicians should be more careful for the other autoimmune diseases, with the patients who experience longer Partial Clinical Remission.